Abstracts voorjaarsvergadering NVU, 16 en 17 mei 2019, Rotterdam

Samenvatting De FUTURE trial is een multicenter RCT naar MRI target biopten (TB’s) bij patiënten met negatieve systematische biopten (SB’s) en een verdenking op prostaatkanker. In deze analyse werden adverse events (AE) van drie technieken van TB vergeleken.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Tijdschrift voor urologie 2019-05, Vol.9 (Suppl 1), p.2-29
1. Verfasser: Mulders, Peter F. A.
Format: Artikel
Sprache:dut
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 29
container_issue Suppl 1
container_start_page 2
container_title Tijdschrift voor urologie
container_volume 9
creator Mulders, Peter F. A.
description Samenvatting De FUTURE trial is een multicenter RCT naar MRI target biopten (TB’s) bij patiënten met negatieve systematische biopten (SB’s) en een verdenking op prostaatkanker. In deze analyse werden adverse events (AE) van drie technieken van TB vergeleken.
doi_str_mv 10.1007/s13629-019-0255-6
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2786217684</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2786217684</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1566-72d1d4c78c786dd3cd653b136c84c1f6d6fb2aba46ae7e011a040d3d6dc2048a3</originalsourceid><addsrcrecordid>eNp1UMFKAzEQDaJgqf0AbwGvXc0k2cl6sxStQlEQ6zVkk2xpsd062Rb8e1O24MlhhpnDvPdmHmPXIG5BCHOXQKG8LwTkkmVZ4BkbSAlQaAPV-WlWQplLNkppLXKgkFDpAXuY1Kkj57vED21La-coHSItXYi02i756-dizAF53HIwfBNXXGaZMX9vuy5ScJsrdtG4rxRHpz5ki6fHj-lzMX-bvUwn88JDiVgYGSBob6qcGILyAUtV57t9pT00GLCppaudRhdNFABOaBFUwOCl0JVTQ3bT8-6o_d7H1Nl1u6dtlrQyU0owWOm8Bf2WpzYlio3d0Wrj6MeCsEevbO-VzU_Yo1cWM0b2mLQ7vhzpj_l_0C82i2jV</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2786217684</pqid></control><display><type>article</type><title>Abstracts voorjaarsvergadering NVU, 16 en 17 mei 2019, Rotterdam</title><source>Alma/SFX Local Collection</source><source>Springer Nature OA Free Journals</source><creator>Mulders, Peter F. A.</creator><creatorcontrib>Mulders, Peter F. A.</creatorcontrib><description>Samenvatting De FUTURE trial is een multicenter RCT naar MRI target biopten (TB’s) bij patiënten met negatieve systematische biopten (SB’s) en een verdenking op prostaatkanker. In deze analyse werden adverse events (AE) van drie technieken van TB vergeleken.</description><identifier>ISSN: 2211-3037</identifier><identifier>EISSN: 2211-4718</identifier><identifier>DOI: 10.1007/s13629-019-0255-6</identifier><language>dut</language><publisher>Houten: Bohn Stafleu van Loghum</publisher><subject>Abstracts ; Medicine &amp; Public Health ; Urology</subject><ispartof>Tijdschrift voor urologie, 2019-05, Vol.9 (Suppl 1), p.2-29</ispartof><rights>The Author(s) 2019</rights><rights>The Author(s) 2019. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s13629-019-0255-6$$EPDF$$P50$$Gspringer$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://doi.org/10.1007/s13629-019-0255-6$$EHTML$$P50$$Gspringer$$Hfree_for_read</linktohtml><link.rule.ids>314,776,780,27901,27902,41096,42165,51551</link.rule.ids></links><search><creatorcontrib>Mulders, Peter F. A.</creatorcontrib><title>Abstracts voorjaarsvergadering NVU, 16 en 17 mei 2019, Rotterdam</title><title>Tijdschrift voor urologie</title><addtitle>Tijdschr Urol</addtitle><description>Samenvatting De FUTURE trial is een multicenter RCT naar MRI target biopten (TB’s) bij patiënten met negatieve systematische biopten (SB’s) en een verdenking op prostaatkanker. In deze analyse werden adverse events (AE) van drie technieken van TB vergeleken.</description><subject>Abstracts</subject><subject>Medicine &amp; Public Health</subject><subject>Urology</subject><issn>2211-3037</issn><issn>2211-4718</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>C6C</sourceid><sourceid>BENPR</sourceid><recordid>eNp1UMFKAzEQDaJgqf0AbwGvXc0k2cl6sxStQlEQ6zVkk2xpsd062Rb8e1O24MlhhpnDvPdmHmPXIG5BCHOXQKG8LwTkkmVZ4BkbSAlQaAPV-WlWQplLNkppLXKgkFDpAXuY1Kkj57vED21La-coHSItXYi02i756-dizAF53HIwfBNXXGaZMX9vuy5ScJsrdtG4rxRHpz5ki6fHj-lzMX-bvUwn88JDiVgYGSBob6qcGILyAUtV57t9pT00GLCppaudRhdNFABOaBFUwOCl0JVTQ3bT8-6o_d7H1Nl1u6dtlrQyU0owWOm8Bf2WpzYlio3d0Wrj6MeCsEevbO-VzU_Yo1cWM0b2mLQ7vhzpj_l_0C82i2jV</recordid><startdate>20190501</startdate><enddate>20190501</enddate><creator>Mulders, Peter F. A.</creator><general>Bohn Stafleu van Loghum</general><general>Springer Nature B.V</general><scope>C6C</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>20190501</creationdate><title>Abstracts voorjaarsvergadering NVU, 16 en 17 mei 2019, Rotterdam</title><author>Mulders, Peter F. A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1566-72d1d4c78c786dd3cd653b136c84c1f6d6fb2aba46ae7e011a040d3d6dc2048a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>dut</language><creationdate>2019</creationdate><topic>Abstracts</topic><topic>Medicine &amp; Public Health</topic><topic>Urology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mulders, Peter F. A.</creatorcontrib><collection>Springer Nature OA Free Journals</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>Tijdschrift voor urologie</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mulders, Peter F. A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Abstracts voorjaarsvergadering NVU, 16 en 17 mei 2019, Rotterdam</atitle><jtitle>Tijdschrift voor urologie</jtitle><stitle>Tijdschr Urol</stitle><date>2019-05-01</date><risdate>2019</risdate><volume>9</volume><issue>Suppl 1</issue><spage>2</spage><epage>29</epage><pages>2-29</pages><issn>2211-3037</issn><eissn>2211-4718</eissn><abstract>Samenvatting De FUTURE trial is een multicenter RCT naar MRI target biopten (TB’s) bij patiënten met negatieve systematische biopten (SB’s) en een verdenking op prostaatkanker. In deze analyse werden adverse events (AE) van drie technieken van TB vergeleken.</abstract><cop>Houten</cop><pub>Bohn Stafleu van Loghum</pub><doi>10.1007/s13629-019-0255-6</doi><tpages>28</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2211-3037
ispartof Tijdschrift voor urologie, 2019-05, Vol.9 (Suppl 1), p.2-29
issn 2211-3037
2211-4718
language dut
recordid cdi_proquest_journals_2786217684
source Alma/SFX Local Collection; Springer Nature OA Free Journals
subjects Abstracts
Medicine & Public Health
Urology
title Abstracts voorjaarsvergadering NVU, 16 en 17 mei 2019, Rotterdam
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-06T00%3A58%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Abstracts%20voorjaarsvergadering%20NVU,%2016%20en%2017%20mei%202019,%20Rotterdam&rft.jtitle=Tijdschrift%20voor%20urologie&rft.au=Mulders,%20Peter%20F.%20A.&rft.date=2019-05-01&rft.volume=9&rft.issue=Suppl%201&rft.spage=2&rft.epage=29&rft.pages=2-29&rft.issn=2211-3037&rft.eissn=2211-4718&rft_id=info:doi/10.1007/s13629-019-0255-6&rft_dat=%3Cproquest_cross%3E2786217684%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2786217684&rft_id=info:pmid/&rfr_iscdi=true